Gopi Shankar, Chief Development Officer at Larimar Therapeutics, Inc. (LRMR), bought 5,000 shares at $3.73 ($19K) on 2023-12-07, disclosed to the SEC on 2023-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.